Skip to main content

Find Clinical Trials

Home
Conditions
CD30-Positive Peripheral T-Cell Lymphoma

Clinical trial condition

CD30-Positive Peripheral T-Cell Lymphoma

Explore clinical trials studying CD30-Positive Peripheral T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

CD30-Positive Peripheral T-Cell Lymphoma trial results

Recruiting

Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain

NCT07624838

Conditions: CD30-Positive Peripheral T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hospital Universitario A Coruña A Coruña, Spain

Hospital Universitari Son Llàtzer Palma de Mallorca, Balearic Islands, Spain

Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain

ICO Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

View all 37 locations

View Trial Details